GLP-1 Drug Trend Drives Premium Whey Protein Demand
Demand for premium whey protein is surging, driven by users of GLP-1 weight-loss drugs seeking high-protein foods.
The growing use of GLP-1 weight-loss medications is fueling a sharp rise in demand for premium whey protein. Industry analysts say consumers on these drugs are turning to high-protein products to maintain muscle mass and feel full while eating less.
According to data from Gallup cited by the report, 11% of US adults were taking GLP-1 medications in 2026, a near quadrupling from 3% in 2024. Adoption in Europe is lower, at just 2%, but nutritional discussions around the drugs are evolving there as well.
GLP-1 Users Shape New Nutritional Needs
A distinct trend is emerging among those using medications like Ozempic and Wegovy. With appetite significantly suppressed, every calorie consumed must deliver more nutritional value. This has pushed the cohort toward meal replacements and snacks that are high in protein but low in volume.
Sandro Schulz, a protein market analyst at Expana, explained the shift. "As a functional ingredient, whey is being used to boost protein and amino acid content across a wide range of applications, from drink powders and ready-to-mix blends to bars and snacks," he said, noting it is a visible beneficiary of the GLP-1 trend.
Supply Struggles Keep Prices High
The surge in demand has strained supply, keeping prices for high-protein whey raise. Schulz provided detailed figures showing that despite recent modest price corrections, costs remain more than double what they were a year ago in key markets.
The price data for Whey Protein Concentrate 80% (WPC80) in August 2026 illustrates the sustained market tightness.
| Market | Price (Late Aug 2026) | Price (Late Aug 2025) | Year-on-Year Change |
|---|---|---|---|
| EU (Instant) | €25,995 per metric ton | €11,700 per metric ton | Up ~122% |
| US (Instant) | $12.25 per pound | $5.25 per pound | Up ~134% |
Schulz noted that production is increasing, but new capacity takes time to come online. In the short term, this points to continued market tightness and sensitivity to any supply disruptions.
Expansion Is a Complex Package Deal
For dairy processors, the high prices make expanding whey production an attractive prospect. However, it presents significant technical challenges. Whey is a by-product of cheese manufacturing; separating it from milk leaves curd behind, which is the fundamental input for cheese.
"Any producer adding whey capacity also has to think through the downstream cheese output that comes with it, and whether there's a genuine use case for that cheese," Schulz explained. This makes capacity decisions a package deal, acting as a natural brake on how quickly the industry can pivot to produce more high-value whey.
Despite these hurdles, the business opportunity is substantial. Protein fortification is a major global trend. Schulz identified protein powders, sports drinks, functional beverages, and protein-fortified snacks as the fastest-growing application categories for whey. Ready-to-drink shakes, powdered blends, and protein bars are also in high demand, as they deliver concentrated nutrition in a small volume.
US and Europe Vie for Future Market Share
Premium whey production is concentrated in North America and Europe. Both regions have invested in expanding capacity, though these projects take years to complete. Market sources expect global demand to keep growing, setting the stage for increased competition between the US and Europe for international market share.
Schulz said the outcome will depend on how well each region can supply its own domestic market and how that domestic demand evolves relative to production expansion. Currently, both regions are primarily focused on meeting demand at home, with cross-border trading for whey remaining limited compared to other dairy commodities.
